Cargando…
Analysis of the Role of TpUB05 Antigen from Theileria parva in Immune Responses to Malaria in Humans Compared to Its Homologue in Plasmodium falciparum the UB05 Antigen
Despite the amount of resources deployed and the technological advancements in molecular biology, vaccinology, immunology, genetics, and biotechnology, there are still no effective vaccines against malaria. Immunity to malaria is usually seen to be species- and/or strain-specific. However, there is...
Autores principales: | Dinga, Jerome Nyhalah, Perimbie, Stephanie Numenyi, Gamua, Stanley Dobgima, Chuma, Francis N. G., Njimoh, Dieudonné Lemuh, Djikeng, Appolinaire, Pelle, Roger, Titanji, Vincent P. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238281/ https://www.ncbi.nlm.nih.gov/pubmed/32276308 http://dx.doi.org/10.3390/pathogens9040271 |
Ejemplares similares
-
TpUB05, a Homologue of the Immunodominant Plasmodium falciparum Protein UB05, Is a Marker of Protective Immune Responses in Cattle Experimentally Vaccinated against East Coast Fever
por: Dinga, Jerome Nyhalah, et al.
Publicado: (2015) -
Enhanced acquired antibodies to a chimeric Plasmodium falciparum antigen; UB05‐09 is associated with protective immunity against malaria
por: Dinga, J. N., et al.
Publicado: (2017) -
Preclinical efficacy and immunogenicity assessment to show that a chimeric Plasmodium falciparum
UB05‐09 antigen could be a malaria vaccine candidate
por: Dinga, J. N., et al.
Publicado: (2018) -
Comparative Transcriptomics of the Bovine Apicomplexan Parasite Theileria parva Developmental Stages Reveals Massive Gene Expression Variation and Potential Vaccine Antigens
por: Atchou, Kodzo, et al.
Publicado: (2020) -
Factors Driving COVID-19 Vaccine Hesitancy in Cameroon and Their Implications for Africa: A Comparison of Two Cross-Sectional Studies Conducted 19 Months Apart in 2020 and 2022
por: Dinga, Jerome Nyhalah, et al.
Publicado: (2022)